Project Grant H8E38944

This $2,130,996 Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) program supports public health activities by the District of Columbia Department of Health (DC Health). Key products and services to be delivered through this five-year award (Aug 2024 - Jul 2029) include: Enhancing epidemiological surveillance and disease reporting capabilities through transitioning to an internal data...

This federal Cooperative Agreement award was made by the Centers for Disease Control and Prevention (CDC) under the Investigations and Technical Assistance program (CFDA 93.283). The $13,207,566 award, with a start date of August 1, 2024 and a completion date of July 31, 2029, is titled "NYS/HRI EPIDEMIOLOGY AND LABORATORY CAPACITY FOR PREVENTION AND CONTROL OF EMERGING INFECTIOUS DISEASES (ELC)". The primary awardee, Health Research, Inc., will use the funding to provide a range of...

Numentus Technologies Inc. received a $303,685 Project Grant award from the National Science Foundation on February 15, 2021 to develop rapid planar PCR technology for COVID-19 testing. The award was made under the NSF's Engineering program (CFDA 47.041) to support innovation and excellence in engineering research. Through this funding, Numentus will work to advance the development of planar PCR, a technology that enables highly sensitive COVID-19 detection on a single integrated testing...

This National Science Foundation (NSF) Engineering program (CFDA 47.041) project grant award to the Rector & Visitors of the University of Virginia (University of Virginia) provides $251,493 to develop optimized pooled testing strategies for efficient COVID-19 prevalence tracking and accurate virus diagnostic testing. The project aims to overcome limitations of traditional group testing methods by designing advanced pooled testing approaches with strong theoretical performance guarantees yet...

This Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) program provides $981,177 to the Mississippi State Department of Health (MSDH) to enhance the state's capacity for infectious disease epidemiology, laboratory testing, and public health response. The five-year project, running from August 1, 2024 to July 31, 2029, aims to maintain a proficient public health workforce, optimize...

The Federated States of Micronesia (FSM) Department of Health and Social Affairs has received a $505,746 Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) program (CFDA 93.323). The grant will fund a five-year project from August 1, 2024 to July 31, 2029 to enhance the department's capacity for detecting, responding to, preventing, and controlling infectious diseases across the...

This $960,000 National Science Foundation project grant supports the development of a multiplexed plasmon-enhanced lateral flow assay for point-of-care detection of SARS-CoV-2 RNA and antigens. Funded under the NSF Engineering program (CFDA 47.041), the grantee, Washington University, will design, validate and build a novel diagnostic platform with sensitivity exceeding standard laboratory tests. Key deliverables include an ultrasensitive multiplexed lateral flow assay for simultaneous...

This Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Epidemiology and Laboratory Capacity for Infectious Diseases (CFDA 93.323) program provides $2,048,852 to the Ohio Department of Health (ODH) to build and strengthen epidemiology, laboratory, and health information systems for detecting, responding to, preventing, and controlling known and (re-)emerging infectious diseases in Ohio. The award supports ODH's work with 111 local health departments...

The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $40.4 million cooperative agreement to Exela Pharma Sciences, LLC (Exela) to expand industrial base capabilities for COVID-19 response. With a period of performance from May 2022 through May 2034, this cooperative agreement will support Exela under the Research on Chemical and Biological Defense program (CFDA 12.360). Through this cooperative agreement, Exela will further the government's...

This Cooperative Agreement award, with a total funding amount of $1,812,750.00, was granted by the Centers for Disease Control and Prevention (CDC) under the Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) program (CFDA 93.323). The purpose of this award is to support the Virgin Islands Department of Health Group, a U.S. local government entity, in enhancing the territory's public health infrastructure for detecting, responding to, preventing, and controlling infectious...